Freshfields Guides Biotech Co. In $325M Funding Round
Germany-based BioNTech, which works on personalized treatments for diseases like cancer, said Tuesday that it has finished up a $325 million funding round guided by Freshfields, calling it one of the...To view the full article, register now.
Already a subscriber? Click here to view full article